<img src="https://ml.globenewswire.com/Resource/Download/02b9253c-4087-4df3-9521-6178c87c18f0?size=2" nborder="0" align="left" hspace="5" vspace="5" title="heron.png" alt="Heron Therapeutics, Inc."/>CARY, N.C., Oct. 26, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, November 9, 2026, at 8:30 a.m. ET to report third quarter financial results and discuss recent business highlights. The conference call can be accessed by phone by utilizing the following <a href="https://www.globenewswire.com/Tracker?data=TJnj4zy-ySU6WLm_50otIclE6GvQSvvCGYLlDSUuaPz5cZGZdXV_kY62PR8zHSc41VKHrctOXQqSQ6bue5BJwSRMK2vjZFcvy5CIPirhIANTVOmhoAdcArnnO3e_1g0BLIOeZc8fLOKTpZUSR38TX4EWUcyKUvWDdIJJJrafgZJIl4wnn8HHEMNToQKmZ3IXcfUc9UzApPvL7N6YRxvXRw==" rel="nofollow" target="_blank" title="registration link">registration link</a> which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron’s website at <a href="https://www.globenewswire.com/Tracker?data=l4Y5AW2zO4IeW9NYD30MwLfzHJ1ZgHpYXQWoaH8zUkzbvnRQumAbC7jNSJZtcokr_3lsujqxTPJ33SW-N50k_4tminjz_BnDocyfxZMgtSpjo3BqulLYz0g8tfv3yctNIrQvWv5qaIouPSlI4GKl-LMXgcYvinj1m448q31liMWosXbsipu-uGdhPqAUTrk43ftwauJrW4G26oCfTayQn3Q7NF0Hm-df8e0gZqWqiiIH2F_QOpMEb08sy6FaOjXexv8JpgzdVm_Ydr2CDBQ-uL3N3wuxOWiFweLF64R73zW6gHiWF3vIUwj-nHENd9wDKyXs0f-_L9fEtBPlDZ98zTGSXyRfhiOSDzzGqx1kokRZ_-UJf-EXtExJlBwaMQdN" rel="nofollow" target="_blank" title="www.herontx.com">www.herontx.com</a>. An archive of the teleconference and webcast will also be made available on Heron’s website for 60 days following the call. About Heron Therapeutics, Inc. Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit <a href="https://www.globenewswire.com/Tracker?data=l4Y5AW2zO4IeW9NYD30MwLsMRcDAvAYoqSP_SucSS5IcAZmHZdUWlCs4x2WzHs7qXx8EZFpZ-T0jFS4JUW_8X1qy_KNqAPjCvsAt2A62OaA=" rel="nofollow" target="_blank" title="www.herontx.com">www.herontx.com</a>. Forward-looking Statements This news release contains “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management’s expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law. Investor Relations and Media Contact: Ira Duarte Executive Vice President, Chief Financial Officer Heron Therapeutics, Inc. <a href="https://www.globenewswire.com/Tracker?data=nKbDTOCp3s2CQFYTbo4491HkkamKk8CRtbF-kWVWtWr-YKTpYIKl8XvOrlLZK8_H2baF0T6OceRO6LLKGchJVnL3fxm_DVxrVi8zPx-PrGo=" rel="nofollow" target="_blank" title="iduarte@herontx.com">iduarte@herontx.com</a> 858-251-4400 <img alt="" src='https://ml.globenewswire.com/media/N2Y0YWI1ZDctYWUzOC00OGU0LTgzY2QtYWM4ZmUwOWNiNWE0LTEwMTkwODUtMjAyNi0xMC0yNy1lbg==/tiny/Heron-Therapeutics-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

Heron Therapeutics to Report Third Quarter 2026 Financial Results  on Monday, November 9, 2026

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn